In the case of BIRC2-3, the drug-response assays and the CRISPR KO data confirmed BIRC2-3 as a potent fitness gene in 11q22.1-2 amplified FA-HNSCC cell lines. Here, BIRC2 is linked to head and neck squamous cell carcinoma.